Malavige GN - Search Results

1

Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac).

Jeewandara C, Fernando S, Pushpakumara PD, Ramu ST, Kamaladasa A, Gunasekara B, Aberathna IS, Kuruppu H, Ranasinghe T, Dayarathne S, Dissanayake O, Gamalath N, Ekanayake D, Jayamali J, Wijesinghe A, Dissanayake M, Somathilake G, Harvie M, Danasekara S, Jayathilaka D, Wijayatilake HDK, Weerasooriya N, Kekulandara C, Schimanski L, Rijal P, Tan TK, Dong T, Townsend A, Ogg GS, Malavige GN. Jeewandara C, et al. Among authors: malavige gn. Sci Rep. 2022 Feb 2;12(1):1727. doi: 10.1038/s41598-022-05788-6. Sci Rep. 2022. PMID: 35110645 Free PMC article.

2

Dengue viral infections.

Malavige GN, Fernando S, Fernando DJ, Seneviratne SL. Malavige GN, et al. Postgrad Med J. 2004 Oct;80(948):588-601. doi: 10.1136/pgmj.2004.019638. Postgrad Med J. 2004. PMID: 15466994 Free PMC article. Review.

3

Persistent high frequencies of varicella-zoster virus ORF4 protein-specific CD4+ T cells after primary infection.

Jones L, Black AP, Malavige GN, Ogg GS. Jones L, et al. Among authors: malavige gn. J Virol. 2006 Oct;80(19):9772-8. doi: 10.1128/JVI.00564-06. J Virol. 2006. PMID: 16973581 Free PMC article.

4

Rapid effector function of varicella-zoster virus glycoprotein I-specific CD4+ T cells many decades after primary infection.

Malavige GN, Jones L, Black AP, Ogg GS. Malavige GN, et al. J Infect Dis. 2007 Mar 1;195(5):660-4. doi: 10.1086/511274. Epub 2007 Jan 22. J Infect Dis. 2007. PMID: 17262706

5

HLA analysis of Sri Lankan Sinhalese predicts North Indian origin.

Malavige GN, Rostron T, Seneviratne SL, Fernando S, Sivayogan S, Wijewickrama A, Ogg GS. Malavige GN, et al. Int J Immunogenet. 2007 Oct;34(5):313-5. doi: 10.1111/j.1744-313X.2007.00698.x. Int J Immunogenet. 2007. PMID: 17845299

6

Phenotypic analysis of human CD4+ T cells specific for immediate-early 63 protein of varicella-zoster virus.

Jones L, Black AP, Malavige GN, Ogg GS. Jones L, et al. Among authors: malavige gn. Eur J Immunol. 2007 Dec;37(12):3393-403. doi: 10.1002/eji.200737648. Eur J Immunol. 2007. PMID: 18034426 Free article.

7

Varicella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors.

Malavige GN, Jones L, Black AP, Ogg GS. Malavige GN, et al. Clin Exp Immunol. 2008 Jun;152(3):522-31. doi: 10.1111/j.1365-2249.2008.03633.x. Epub 2008 Mar 20. Clin Exp Immunol. 2008. PMID: 18363743 Free PMC article.

8

Viral load, clinical disease severity and cellular immune responses in primary varicella zoster virus infection in Sri Lanka.

Malavige GN, Jones L, Kamaladasa SD, Wijewickrama A, Seneviratne SL, Black AP, Ogg GS. Malavige GN, et al. PLoS One. 2008;3(11):e3789. doi: 10.1371/journal.pone.0003789. Epub 2008 Nov 21. PLoS One. 2008. PMID: 19023425 Free PMC article.

9

Immune evasion during varicella zoster virus infection of keratinocytes.

Black AP, Jones L, Malavige GN, Ogg GS. Black AP, et al. Among authors: malavige gn. Clin Exp Dermatol. 2009 Dec;34(8):e941-4. doi: 10.1111/j.1365-2230.2009.03350.x. Epub 2009 Jun 22. Clin Exp Dermatol. 2009. PMID: 19549245

10

Tracking epitope-specific antiviral CD4+ T cell responses to a live attenuated vaccine reveals ongoing functional responses.

Jones L, Malavige G, Jeffery K, Kemp E, Breuer J, Klenerman P, Ogg GS. Jones L, et al. Vaccine. 2009 Dec 9;27(52):7398-401. doi: 10.1016/j.vaccine.2009.08.081. Epub 2009 Sep 8. Vaccine. 2009. PMID: 19744587

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

132 results

Search Page